title: [Interstitial irradiation of carcinoma of the tongue].
abstract: From 1977 to 1988, 61 patients have received radical treatment for a carcinoma of the mobile tongue. Fifty-nine of these patients were treated in association with a BLM (or PEP), and 26 patients with external irradiation. The local tumor control rate at two years was 77%, and subsequent lymph node metastasis was 25%. The five year cumulative survival rate was 55% and the main causes of death were found to be regional node metastases and other related diseases particularly. The determinate survival for TxN0 tumors was 83%. Six percent and 26% had radio-osteonecrosis and soft tissue necrosis respectively and three patients required surgery.
authors: Dept. of Radiology, Yamagata Univ. Med. School.
authors: J
authors: J
authors: Watarai
authors: M
authors: M
authors: Nozue
authors: T
authors: T
authors: Haga
authors: K
authors: K
authors: Yamaguchi
authors: T
authors: T
authors: Itagaki
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001761:Bleomycin / Q000627:therapeutic use; D001918:Brachytherapy / Q000009:adverse effects; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy*; D003131:Combined Modality Therapy; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D010025:Osteoradionecrosis / Q000209:etiology; D017663:Peplomycin; D011832:Radiation Injuries / Q000209:etiology; D012074:Remission Induction; D014062:Tongue Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy*
chemical_list: D001761:Bleomycin; D017663:Peplomycin